How Has Medtronic’s Revenue Mix Changed In The Last five Years?

+14.78%
Upside
83.66
Market
96.03
Trefis
MDT: Medtronic logo
MDT
Medtronic

Following the Covidien acquisition, the Surgical and Patient Monitoring products segment has become the most important segment for Medtronic  (NYSE:MDT). This comes from the fact that, apart from certain vascular and surgical products, there was little product overlap between the segments of Medtronic and Covidien. The Covidien acquisition has helped Medtronic expand its presence in the minimally-invasive surgical market. Medtronic has been able to add a diverse range of products, primarily medical devices and medical supplies, to its portfolio. The medical devices include surgical products, vascular products, as well as respiratory and monitoring products. The medical supplies products include monitoring and operating room products, needles and syringes, nursing care, skincare products, hydrogels and animal health products.

MDT_Revenue_Comp

1) If you like or have any questions about our analysis, please write us back at content@trefis.com. We hope such lean communication sparks thinking, and encourages you to ask questions. The purpose of these analyses is to help you focus only on a few important things.
2) Figures mentioned are approximate values to help our readers remember the key concepts more intuitively.

See More at Trefis | View Interactive Institutional Research (Powered by Trefis)

Relevant Articles
  1. What’s Next For Medtronic Stock After An Upbeat Q3?
  2. Up Just 6% In 2023 Is Medtronic Stock A Better Pick Over Abbott?
  3. Should You Pick Medtronic Stock At $80 After An Upbeat Q2?
  4. After A 6% Rise This Month Should You Pick Medtronic Stock Ahead of Its Q2?
  5. Should You Buy Medtronic Stock After A Q1 Beat?
  6. Will Medtronic Stock Rebound To Its Pre-Inflation Shock Highs?

Get Trefis Technology